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Abstract
In the past decades, chronic inflammatory diseases such as psoriasis, atopic dermatitis, asthma, Crohn’s disease and celiac
disease were generally regarded as immune-mediated conditions involving activated T-cells and proinflammatory cytokines
produced by these cells. This paradigm has recently been challenged by the finding that mutations and polymorphisms in
epithelium-expressed genes involved in physical barrier function or innate immunity, are risk factors of these conditions. We
used a functional genomics approach to analyze cultured keratinocytes from patients with psoriasis or atopic dermatitis and
healthy controls. First passage primary cells derived from non-lesional skin were stimulated with pro-inflammatory
cytokines, and expression of a panel of 55 genes associated with epidermal differentiation and cutaneous inflammation was
measured by quantitative PCR. A subset of these genes was analyzed at the protein level. Using cluster analysis and
multivariate analysis of variance we identified groups of genes that were differentially expressed, and could, depending on
the stimulus, provide a disease-specific gene expression signature. We found particularly large differences in expression
levels of innate immunity genes between keratinocytes from psoriasis patients and atopic dermatitis patients. Our findings
indicate that cell-autonomous differences exist between cultured keratinocytes of psoriasis and atopic dermatitis patients,
which we interpret to be genetically determined. We hypothesize that polymorphisms of innate immunity genes both with
signaling and effector functions are coadapted, each with balancing advantages and disadvantages. In the case of psoriasis,
high expression levels of antimicrobial proteins genes putatively confer increased protection against microbial infection, but
the biological cost could be a beneficial system gone awry, leading to overt inflammatory disease.
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Introduction
Psoriasis vulgaris and atopic dermatitis are two common
chronic inflammatory skin diseases, characterized by various
different clinical and histological features depending on the stage
of the disease. Although both diseases are generally regarded as
immune-mediated conditions, recent genetic studies have indicat-
ed the importance of abnormalities in epithelium-expressed genes
as a primary cause. Loss of function alleles of the skin barrier
protein filaggrin were found to be a major predisposing factor for
atopic dermatitis[1], and we have recently demonstrated that a
copy number polymorphism of a beta defensin gene cluster was
associated with increased risk for psoriasis[2].
Lesional skin of patients with psoriasis or atopic dermatitis is
heavily infiltrated with activated T cells that produce proinflam-
matory cytokines including those designated as Th1 cytokines (e.g.
interferon-gamma (interferon-c) and tumor necrosis factor alpha
(TNF-a)) or Th2 cytokines (e.g. interleukin (IL)-4, IL-5 and IL-13).
Psoriasis is generally regarded as a disease dominated by Th1
cytokines, whereas atopic dermatitis, particularly in active lesions,
is driven by Th2 cytokines. Atopic dermatitis skin shows a high
frequency of bacterial colonization and recurrent skin infections by
bacterial, fungal, and viral pathogens. In contrast, a large
epidemiological study on disease concomitance in psoriasis
revealed that psoriasis patients have an increased resistance to
bacterial and viral infections compared with controls and atopic
dermatitis patients[3]. Several studies have shown that expression
levels of antimicrobial proteins such as hBD-2, LL-37 and SLPI
are significantly decreased in lesional atopic dermatitis skin
compared with lesional psoriatic skin[4,5]. It was speculated that
a relative deficiency in expression of innate immunity genes in
atopic dermatitis patients could account for the susceptibility to
skin infection with Staphylococcus aureus[4]. In addition, microarray
analysis on lesional skin of psoriasis and atopic dermatitis patients
revealed a specific difference in the profile of expressed
proinflammatory cytokines and chemokines[6]. These findings
raised the question whether these differences are an acquired
characteristic caused by extrinsic factors such as the inflammatory
infiltrate and the cytokine environment, or alternatively could be
driven by differences in genetic programming of epidermal
keratinocytes in psoriasis and atopic dermatitis. Clearly, these
mechanisms are not mutually exclusive. A few recent in vitro studies
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have shown that differences in the cytokine environment could be
responsible for the observed differences in antimicrobial gene
expression, as it was shown that IL-4, IL-13 and IL-10
downregulate defensin expression[7,8].
As the epidermal inflammatory response of psoriasis and atopic
dermatitis patients shows two opposite directions (i.e. high and low
expression of host defense genes), the aim of the present study was
to investigate if cell-autonomous differences exist between
keratinocytes from psoriasis and atopic dermatitis patients. Our
results show that the genetic programming of keratinocytes from
psoriasis or atopic dermatitis patients is different between both
diseases with respect to expression of genes involved in cutaneous
inflammation and host defense.
Results
To create an in vitro model system to examine differences
between keratinocytes from various diseases, we used a well-
defined submerged keratinocyte culture model. First passage
normal human keratinocytes were cultured in serum-free kerati-
nocyte growth medium (KGM), and differentiation was induced
by growth factor withdrawal, which causes the expression of
differentiation-related proteins such as cytokeratin 10 and
transglutaminase-1, as described before[9]. In this model that
resembles normal human epidermis, disease-associated markers
for epidermal activation (e.g. b-defensin-2 (hBD-2), psoriasin and
elafin) are expressed at low to undetectable levels which makes it a
suitable and sensitive model to study keratinocyte activation by
inflammatory stimuli[10]. To mimic an inflammatory milieu as
found in psoriasis, we stimulated normal human keratinocytes with
a mixture of interferon-c, TNF-a and IL-1a (pro-inflammatory
cytokines; further referred to as Th1 cytokine mix). A combination
of IL-4 and IL-13 was used as a Th2 cytokine mix, to resemble the
atopic dermatitis cytokine microenvironment of active lesions.
After 48 hours the culture supernatants were harvested and the
mRNA was extracted from the cells for qPCR. It was found that
Th1 cytokines induce a dose-dependent increase in expression of
the psoriasis-associated gene DEFB4, which encodes the hBD-2
protein (Figure 1a). We found that Th2 cytokines did not induce
expression of hBD-2 (not shown) but instead could dose-
dependently induce the expression of carbonic anhydrase-2
(CA2) (Figure 1b), a gene previously found to be overexpressed
in lesional atopic dermatitis skin[11] under control of Th2
cytokines[12]. Th1 cytokines did not induce expression of CA2
(not shown). These experiments exemplify how normal human
keratinocytes are programmed to respond to Th1 or Th2
cytokines, with respect to these marker genes.
We used the model system, as described above, to expose cells to
relevant stimuli that induce a disease-specific read-out in vitro.
Therefore we tested 21 cell lines of primary keratinocytes derived
from psoriasis patients, atopic dermatitis patients and healthy
controls (cell cultures of uninvolved skin, from 7 donors for each
group). mRNA from these cultures was used for quantitative
analysis of a large panel of genes to examine if there were
diagnosis-specific differences in expression profiles of resting or
cytokine-stimulated keratinocytes. Genes to be analyzed were
selected from the available literature on gene expression in lesional
skin of psoriasis and atopic dermatitis[5,6,11,13] and from a
microarray study that we conducted on purified epidermal cells
from lesional skin of psoriasis and atopic dermatitis patients. The
experimental details and raw data of this study have been
deposited in the NCBI Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo) and are accessible through GEO
Series accession number GSE6601. The microarray study
revealed 183 genes that showed significant differential expression
between psoriasis and atopic dermatitis, and a number of genes
from this list were selected for the present study (Table S1). The
selected gene set comprised mainly genes involved in host defense
and inflammation, such as antimicrobial proteins, cytokines and
chemokines. We also included a number of genes that encode
structural epidermal proteins such as cytokeratins 6, 10, 14 and 17,
involucrin and connexin 43. Table S1 lists the primer sequences of
56 selected genes that were analyzed by qPCR on the 21 cell lines
from patients and controls, cultured without stimulus or exposed
to Th1 or Th2 cytokines. Table S2 contains the raw data of all
qPCR analyses.
We used a two-way clustering approach to analyze the structure
of the data and to obtain a visual representation of the similarity
between keratinocyte cultures, and genes that behave similarly
across the different cell cultures (Figure 2). Clustering of the
keratinocyte cultures clearly separates the Th1-stimulated cells (all
samples under node A in Figure 2, referred to as cluster A) from
the non-stimulated and Th2-stimulated cells, irrespective of their
donor origin (all samples under node B, referred to as cluster B).
This confirms and extends previous in vitro data indicating that
cytokines like IL-1 and TNF-a strongly induce the expression of
host defense genes such as members of the b-defensin family[14]
Figure 1. Cytokine-induced gene expression of DEFB4 and CA2
in cultured keratinocytes. (A) The Th1 cytokine mixture (IL-1a/TNF-
a/interferon-c) induces a dose-dependent increase of DEFB4 expression
both for mRNA (grey bars) and protein (black bars); mean6SD of three
cultures. Th1 cytokines concentrations used are in ng/ml (IL-1a and
TNF-a) or U/ml (interferon-c) respectively: A =no stimulus; B = 1.7 ng/
1.7 ng/0.5 U; C = 5 ng/5 ng/1.7 U; D= 10 ng/10 ng/3.3 U; E = 30 ng/
30 ng/10 U. (B) The Th2 cytokine mixture (IL-4/IL-13) induces a dose-
dependent increase in mRNA and protein expression of the CA2 gene
(mean6SD of five cultures). Cytokine concentrations are in ng/ml.
A =no stimulus; B = 0.08 ng/0.08 ng; C = 0.4 ng/0.4 ng; D= 2 ng/2 ng;
E = 10 ng/10 ng; and F = 50 ng/50 ng.
doi:10.1371/journal.pone.0002301.g001
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and c-interferon enhances this response. These findings support
the notion that the cytokine environment in vivo is one of the
factors that drive epidermal gene expression as seen in various
diseases. Within cluster A, there is segregation of the psoriasis and
atopic dermatitis cell lines with minimal overlap. Under node C,
six out of seven psoriatic cell lines are clustered with two cell lines
Figure 2. Two-way clustering of samples and expressed genes. Cluster analysis was performed on expression levels of 51 genes in 63 samples
of cultured keratinocytes from healthy individuals (NS), psoriasis patients (PS) and atopic dermatitis patients (AD). Cells were left untreated (KGM) of
stimulated with cytokines (Th1 and Th2). Only those genes that passed the test for false discovery rate (51 out of 55) were included in the analysis.
qPCR data were subjected to Z-transformation and the Euclidian distance was used as a dissimilarity measure. Columns and rows were clustered by
Ward’s amalgamation rule. Sorting in two dimensions reorganizes the data and generates an expression matrix depicted as a heat-map in which each
cell was assigned a color corresponding to its normalized value. Gene clusters on the horizontal axis are numbered (1–2) as described in the text.
Clusters of samples on the vertical axis are labeled A–E as described in the text.
doi:10.1371/journal.pone.0002301.g002
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from normal individuals, whereas all atopic dermatitis cell lines are
clustered under node D together with the remaining cell lines (one
psoriasis and five normal individuals). Within cluster B (all non-
stimulated and Th2 stimulated cell lines) clustering is less compact,
although a homogeneous cluster of exclusively Th2 stimulated
cells (under node E) can be discerned. This illustrates that
keratinocytes derived from psoriasis patients can be discriminated
from those of atopic dermatitis individuals on the basis of Th1-
cytokine induced gene expression. On the horizontal axis of
Figure 2 several clusters of putatively co-regulated genes are
evident. Although the heat map reveals a large number of genes
that show induction by Th1 cytokines, cluster 1 appears as a
particularly compact cluster that contains a set of genes (CXCL10,
IL1F9, DEFB4, S100A8, S100A9), which are strongly induced by
Th1 cytokines in all diagnoses, compared to KGM and Th2
cytokines. Cluster 2, containing CA2 and NELL2, represents a
small class of genes that are upregulated by Th2 cytokines. The
reason that these two genes were included in our set was the
reported in vivo overexpression in atopic dermatitis skin compared
to psoriasis[11]. Our data basically show two things. Firstly,
keratinocyte gene expression is strongly influenced by the
respective cytokine environments regardless of the origin of the
cells, and lends further support to the Th1/Th2 cytokine concept
in psoriasis and atopic dermatitis. Secondly, the segregation of
psoriasis and atopic dermatitis patients by cluster analysis points at
cell-autonomous differences between keratinocytes of these
patients.
An exploratory statistical approach like cluster analysis is a
useful strategy to analyze the structure of the data but does not
allow testing for significance. Therefore the qPCR data (DCt
values) were analyzed using a repeated factorial ANOVA design,
combined with a recently described method for controlling the
False Discovery Rate (FDR) instead of the older Family Wise
Error Rate (FWER) by the classical Bonferroni or sequential
Bonferroni tests like Holm’s Step Down Test[15]. The two factors
analyzed were ‘diagnosis’ (normal skin, psoriasis, atopic dermatitis)
and ‘stimulation’ (KGM, Th1 cytokines, Th2 cytokines). A
Duncan post-hoc test was performed to analyze all the single
factors that remained significant after FDR testing. Figure 3
summarizes the p-values of the ANOVA, FDR and the post-hoc
tests for all genes. This analysis showed that 48 genes were
significantly regulated by the factor stimulation (column "Stim" in
Figure 3). The last two columns of Figure 3 show the p-values of
the individual genes for Th1 and Th2 stimulation. Although both
Th1 and Th2 cytokines caused significant differences in gene
expression, their effects are qualitatively and quantitatively
different. Table S3 gives the least square means of the DCt values
of all genes and the calculated fold stimulation. It is shown that
Th1 cytokines have a strong stimulatory effect on expression of
many genes involved in innate immunity and host defense, such as
antimicrobial proteins (e.g. DEFB104, PI3, S100A8, S100A9),
chemokines (e.g. CXCL10, CCL20, CCL27, CCL5 and IL8) and
cytokines (e.g. IL1F9 and TNF). Th2 cytokines had either no effect
or slight inhibitory effects on most genes, but increased the
expression of NELL2, CA2 and TNC (more than 4-fold). The
corresponding proteins of Th2-induced genes have diverse
functions not normally associated with inflammation or host
defense. As shown in Figure 2 we observed diagnosis-specific
clustering of keratinocyte cell lines on the basis of gene expression
data. The ANOVA data presented in Figure 3 indicate that
expression levels of 21 genes were significantly regulated by the
factor diagnosis. For 9 genes a significant cross-effect was found.
Table S3 shows the fold difference between expression levels of
genes, comparing the different diagnoses. For a substantial
number of genes, the expression levels in psoriasis are considerably
higher than in atopic dermatitis cells. These findings show that
innate immunity genes, both encoding signaling molecules (e.g.
IL8, IL1B, CXCL1) and effector molecules (DEFB4, DEFB103,
PI3) are overexpressed by psoriasis keratinocytes compared to
atopic dermatitis. Figures 4A, 4D, and 4E give a graphical
representation of qPCR data from DEFB103, DEFB4 and PI3, as
an example of innate immunity genes that are strongly induced by
Th1 cytokines and show a significant diagnosis-specific response.
For comparison, the expression of KRT14 and KRT6 is shown in
Figures 4B and 4C as an example of two structural cytokeratins
that are not cytokine-inducible and do not show diagnosis-specific
differences.
The throughput and accuracy of analysis at the mRNA level is
currently not matched by analysis at the protein level, although
this would be desirable for obvious reasons. We selected a number
of genes included in the study described above, for which
immunoassays were available as ELISA or fluorescent bead assays
(hBD-2, elafin, SLPI, CXCL8, RANTES and IP-10).We found
stimulus-specific and diagnosis-specific differences for most
proteins (factorial ANOVA, followed by post-hoc testing, see
Table S4 for raw protein data, and Table S5 for p-values). All six
genes selected for protein analysis were induced by Th1 cytokines,
and for most proteins the expression by atopic dermatitis
keratinocytes was significantly lower than for normal skin or
psoriasis keratinocytes. A comparison of qPCR and protein data is
shown for DEFB4 (hBD-2) (Figure 4D and G), PI3 (elafin)
(Figure 4E and H) and CCL5 (RANTES) (Figure 4F and I) of the
63 cultures. The protein data largely confirm the mRNA data.
Discussion
Our in vitro findings suggest that the observed high expression
levels of innate immunity genes that have been reported in lesional
skin of psoriasis patients compared to atopic dermatitis[4,5], can
be caused both by extrinsic factors (cytokines) and cell-autono-
mous (disease-specific) factors. We designed this study to use
qPCR on a selected number of genes, many of which were for a
priori reasons relevant to our question, based on known in vivo
expression data. The restriction on the number of genes we
analyzed, given a modest number of samples, circumvents
methodological problems associated with other large scale
expression studies such as microarray analysis that often preclude
proper statistical analysis due to a high false discovery rate and
huge family-wise errors. In addition, the accuracy and specificity
of qPCR compared to microarray analysis further augments the
power of this approach. To our knowledge there are no studies
available that have performed large-scale analyses on keratinocytes
from individuals with different diagnoses. Previous small-scale
studies that have addressed in vitro differences between normal
keratinocytes and/or keratinocytes from psoriasis and atopic
dermatitis patients, did not detect significant cell-autonomous
differences[16,17]. A study on in vitro expression of a limited
number of chemokines by cultured keratinocytes, using semi-
quantitative PCR, suggested disease-specific differences between
psoriasis and atopic dermatitis[18], although this concept was not
supported in more recent studies[7,19]. The failure to detect cell-
autonomous differences could be explained by various methodo-
logical reasons such as experimental design, the genes selected for
read-out, or the nature of the stimuli and the sensitivity of the
culture system to detect differences. Cell-autonomous differences
have previously been detected in cultured bronchial epithelial cells
derived from patients with atopic asthma and healthy non-atopic
controls[20]. A deficient response to rhinovirus was observed in
Host Defense in Skin Diseases
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cells from asthmatics, showing a decreased production of
interferon-b, impaired apoptosis and increased virus replication.
In atopic dermatitis, there is also evidence for increased sensitivity
to infections, but this appeared to be secondary to exposure of
keratinocytes to a Th2 milieu, resulting in suppression of
expression of the antimicrobial peptide hCAP-18 (LL-37)[8]. In
line with this, we observed that addition of Th2 cytokines to Th1
cytokines resulted in a marked suppression of the ability of Th1
cytokines to induce expression of hBD-2 and SLPI in keratinocytes
from all subject groups (data not shown).
Figure 3. Summary of qPCR data. All genes that remained significant after FDR testing (third column), were used for factorial ANOVA. The p-
values for the factor ’diagnosis’ (normal skin (NS), psoriasis (PS) and atopic dermatitis (AD)), the factor ’stimulus’ (KGM, Th1 and Th2) and the cross-
effect (DiagStim) are in columns 4–6. The p-values for comparison between groups are given in columns 7–17, Post-hoc, Duncan’s multiple range
test. p-values ,0.05 are marked in red.
doi:10.1371/journal.pone.0002301.g003
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We interpret our findings in a way that differences exist in
genetic programming of keratinocytes from psoriasis or atopic
dermatitis patients with respect to expression of genes involved in
cutaneous inflammation and host defense. We do not think that
the observed differences are caused by ’simple’ differences or
polymorphisms in one or two genes. They are probably the
outcome of a summation of many subtle polymorphisms, that
would be undetectable by a genome-wide association study
because of the very small relative risks associated with each factor.
The summation of these genetic factors, which we would call ’the
genetic network’ would alter the basic ’setting’ of the epidermal
keratinocyte with respect to host defense or response to stress and
infection.
Remarkably, these cell-autonomous differences were also noted
when unstimulated, non-lesional cells of patient groups were
compared, although the differences were most pronounced upon
stimulation by Th1 cytokines. Based on qPCR analysis, ANOVA
showed highly significant differences between diagnoses for the
entire model and in many cases also for individual genes. Although
the data set of the protein assays was substantially smaller than
that of the qPCR assays, we did observe significant diagnosis-
specific effects for 5 proteins (see Table S5). At the level of
individual genes, cytokine-stimulated keratinocytes from psoriasis
patients produced significantly higher levels of elafin and hBD-2
than keratinocytes from atopic dermatitis patients (see Figure 4).
Although we interpret the observed differences between psoriasis
and atopic dermatitis keratinocytes to be genetically programmed,
one should bear in mind that other mechanisms could be involved
as well. A possible explanation for the differences in diagnosis-
specific gene expression could be epigenetic mechanisms that are
induced in the keratinocytes by the underlying disease. To date
there is no evidence that this is the case, but it is an intriguing
possibility that requires further investigation. An alternative
explanation which has been coined repeatedly over the last several
decades, is an occult viral infection in psoriasis, although this was
never confirmed by independent studies[21].
Previous understanding of diseases such as psoriasis and atopic
dermatitis has focused on mechanisms of the adaptive immune
system, often with emphasis on the Th1-Th2 paradigm. Our
present data, and findings from genetic association studies in
atopic dermatitis[1], Crohn’s disease[22,23] and psoriasis[2]
suggest that further understanding of innate immunity and barrier
function of the epithelium is essential. We suggest that clusters of
innate immunity genes, both with signaling and effector functions,
Figure 4. Graphical representation of mRNA and protein expression of selected genes. qPCR data of DEFB103, KRT14 and KRT6 (A–C); no
significant effect of stimulus or diagnosis was found for expression of the cytokeratins KRT14 and KRT6, whereas the antimicrobial peptide DEFB103
(hBD-3) showed a significant effect both for stimulus and diagnosis. Statistical analysis was performed by ANOVA and post-hoc testing by Duncan’s
multiple range test, see Figure 3 for p-values, see Table S2 for raw data. qPCR data (D–F) and secreted protein levels (G–I) in the culture supernatant;
the host defense genes DEFB4 (hBD-2) and PI3 (elafin), and the chemokine CCL5 (RANTES) show similar patterns of expression at the mRNA and
protein level. A significant effect of stimulus and diagnosis was found by ANOVA and post-hoc testing by Duncan’s multiple range test; see Figure 3
(qPCR) and Table S5 (protein assays) for p-values. qPCR data (A–F) are given in mean and standard error of seven cultures, protein data (G–I) in mean
and standard deviation of seven cultures.
doi:10.1371/journal.pone.0002301.g004
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are coadapted, each with balancing advantages and disadvantages.
We interpret disease states, which are clinically defined as psoriasis
or atopic dermatitis, as the pleiotropic effects of these coadapted
polymorphisms. The ultimate outcome is reflected by activity or
levels of expressed protein leading to functional consequences in
physiology and, sometimes, a phenotypic manifestation known as
disease. In the case of psoriasis, epidermal keratinocytes could
have lower thresholds for expression of innate immunity genes
(antimicrobials, chemokines), which would confer increased
protection against microbial infection. There is evidence from
epidemiological studies that the latter is indeed the case[3]. The
biological cost of increased protection would be a beneficial system
gone awry that leads to overt chronic inflammatory disease. The
disease mechanism could involve excessive cytokine production
and a genetically determined epidermal hypersensitivity to these
factors derived from the local, possibly autoreactive, T-cell
infiltrate. The causes of the cutaneous infiltration by T-cells and
the nature of this increased spontaneous and cytokine-induced
expression of host defense genes are currently unknown. The
mechanisms of increased gene expression levels in psoriatic
keratinocytes could be at the level of cell surface receptors, or
more likely in the downstream signaling cascades. Speculatively,
this could involve MAPkinase and/or NFkB signaling, as many of
the genes overexpressed in psoriatic skin (e.g. DEFB4, PI3 and IL8)
are regulated by these pathways[24–26]. The beta defensin cluster
on chromosome 8p23 presents a special case of innate immunity
genes associated with psoriasis, as their increased expression can be
explained by three mechanism: increased copy number, Th1
cytokine stimulation of keratinocytes, and a cell-autonomous low
threshold for cytokine stimulation. Also in atopic dermatitis the
current emphasis is now moving away from an exclusive focus on
adaptive immunity as the primary cause, towards local responses in
the epithelium and quality of epidermal barrier function[1,27].
With respect to expression of innate immune genes in atopic
dermatitis epidermis, at least two distinct mechanisms could be
operative. In (sub)acute lesions Th2 cytokines dominate over Th1
cytokines, which would prevent the induction of a strong host
defense response, as we have indeed found when keratinocytes
were exposed to mixtures of Th1 and Th2 cytokines (data not
shown). Furthermore, we provide evidence for an additional
mechanism by showing that atopic dermatitis keratinocytes are less
responsive to the stimulatory effect of pro-inflammatory Th1
cytokines on expression of host defense mechanisms. Both
mechanisms are in line with previous observations showing
decreased expression of host defense proteins in atopic dermatitis
skin[4,5], which may explain the observed high frequency of
infections in atopic dermatitis as compared to psoriasis[3].
Collectively, our data warrant a re-appraisal of the role of
epidermal keratinocytes in inflammatory skin diseases[27,28].
Materials and Methods
Microarray analysis
The microarray platform used was a printed 19 K oligonucle-
otide set (18,861 oligonucleotides representing 18,664 unique
sequences) from Sigma-Genosys, Cambridge, UK). Detailed
procedures for preparation of purified epidermis, RNA purifica-
tion, linear RNA amplification, probe labeling, array printing,
array hybridization and microarray analysis have been published
elsewhere[5]. Experimental data on gene expression levels in
lesional psoriasis and atopic dermatitis epidermal cells have been
deposited, compliant with MIAME criteria, at http://www.ncbi.
nlm.nih.gov/geo/ and are accessible through GEO Series
accession number GSE6601.
Cell culture
Primary human epidermal keratinocytes were cultured from
skin biopsies of psoriasis patients (n = 7), atopic dermatitis patients
(n = 7) and healthy volunteers (n = 7), following the Rheinwald-
Green system[29], and stored in liquid nitrogen until use.
Permission for these studies was obtained from the local medical
ethics committee (Commissie Mensgebonden Onderzoek Arn-
hem-Nijmegen), and volunteers gave written informed consent.
The study was conducted according to the Declaration of Helsinki
principles. Biopsies were from trunk skin, and in the case of
patients, biopsies were taken from distant uninvolved (non-
lesional) skin of the trunk. All psoriasis patients had plaque-type
psoriasis. Atopic dermatitis was diagnosed according to the
Hanifin criteria, and included three intrinsic and four extrinsic
type patients. All diagnoses were made by a dermatologist. Patient
groups consisted of adult individuals aged 43617 for psoriasis
patients, 37614 for atopic dermatitis patients and 31613 for
healthy controls (mean and SD). First-passage cells were cultured
to confluency in keratinocyte growth medium (KGM), and
induced to differentiate by growth factor depletion as described
before[10]. Differentiating cell cultures were stimulated with Th1
cytokines (30 ng/ml IL-1a, 30 ng/ml TNF-a, 10 U/ml interferon-
c), Th2 cytokines (50 ng/ml IL-4 and 50 ng/ml IL-13), or left
untreated (control). IL-1a, TNF-a, IL-4 and IL-13 were obtained
from Peprotech and interferon-c from HyCult Biotechnology.
After 48 hrs the supernatant was collected and the cells were
harvested for mRNA isolation.
Quantitative real-time PCR
First-strand cDNA was generated from mRNA and the reverse
transcriptase reaction products were used for quantitative real-
time PCR, which was performed with the MyiQ Single-Colour
Real-Time Detection System for quantification with Sybr Green
and melting curve analysis (Bio-Rad) as previously described[30].
Primers were designed using Primer Express 1.0 Software (Applied
Biosystems) and produced by Biolegio. Primer validation, qPCR
reactions, and determination of relative mRNA expression were
performed as previously described[5]. Expression of target genes
was normalized to that of human ribosomal phosphoprotein P0
(RPLP0). This housekeeping gene was not found to be subject to
regulation in keratinocyte cultures, irrespective of stimulation or
diagnosis, and is more reliable than other reference genes such as
ACTB (actin) or GAPDH (data not shown). Statistical analysis was
performed as described below and in Text S1. For graphical
representation of qPCR data (as in Figures 1 and 3) the method
described by Livak[31] was used, and the mean expression level of
non-stimulated (KGM) keratinocytes from normal skin (NS) was
assigned the value 1. See Table S1 for primer sequences.
Protein assays
Protein concentrations for IP-10 and RANTES were deter-
mined with the Bio-Plex fluorimetric bead assay (Bio-Rad),
according to the manufacturer’s protocol. ELISA assays for elafin
and SLPI were performed as described previously[32,33]. ELISA
for hBD-2 was performed using antisera against recombinant
hBD-2 (Peprotech). An ELISA kit for the detection of CXCL8 was
used in accordance to the protocol provided by the manufacturer
(Biosource). CA2 protein levels were determined as described
previously[12].
Statistics
All data were analyzed with the Statistica software package
version 7.0 (StatSoft Inc). All data and a detailed description of the
Host Defense in Skin Diseases
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statistical procedures are given as supplementary Tables S2 and
S4, and Text S1.
Supporting Information
Table S1 list of genes (approved gene symbols, protein names)
and primers used for qPCR
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